Pathogenesis-directed therapy of methylphenidate-induced oxidative heart damage in rats
Özet
Aim: The current study aimed to investigate the protective effects of adenosine triphosphate (ATP), metyrosine, and melatonin on possible methylphenidate cardiotoxicity in rats using biochemical and histopathological methods. Methods: Thirty rats were separated into five groups: healthy (HG), methylphenidate (MP), ATP + methylphenidate (ATMP), metyrosine + methylphenidate (MSMP), and melatonin + methylphenidate (MLMP). ATP (5 mg/kg) was given intraperitoneally once daily, metyrosine (50 mg/kg) orally twice daily, and melatonin (10 mg/kg) orally once daily. Methylphenidate (10 mg/kg) was administered orally once daily for 1 h after ATP, metyrosine and melatonin. The protocol was repeated for 30 days. Subsequently, blood samples were taken from the tail veins of the animals to measure adrenaline, noradrenaline, dopamine, troponin I (TP I) and creatine kinase MB (CK-MB) levels; the animals were then euthanized and the heart tissues were extracted. Tissues were analyzed for malondialdehyde (MDA), total glutathione (tGSH), superoxide dismutase (SOD), and catalase (CAT) and histopathologically. Results: In MP group, MDA, adrenaline, noradrenaline, dopamine, TP I, and CK-MB levels increased (p < 0.001) and tGSH, SOD, and CAT levels decreased (p < 0.001) compared to HG, and histopathologic damage developed. Oxidant levels were lower and antioxidant levels were higher in ATMP, MSMP, and MLMP groups compared to MP group (p < 0.001). Catecholamine levels were measured lower in the MSMP group compared to the MP group (p < 0.001). TP I and CK-MB levels were lower in ATMP, MSMP and MLMP groups compared to MP (p < 0.05), with the lowest being in rats given ATP (p < 0.001). ATP, melatonin, and metirozin applications were effective to different degrees in preventing histopathological changes. Conclusion: This study may guide clinical trials using ATP and melatonin to prevent methylphenidate-induced myocardial injury. Copyright © 2025 Emir, Bulut, Suleyman, Mammadov, Yucel, Cicek, Yazici, Altuner, Gunay and Suleyman.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Emir, Izzet | |
| dc.contributor.author | Bulut, Seval | |
| dc.contributor.author | Suleyman, Bahadır | |
| dc.contributor.author | Mammadov, Renad | |
| dc.contributor.author | Yucel, Nurinisa | |
| dc.contributor.author | Cicek, Betul | |
| dc.contributor.author | Yazici, Gulce Naz | |
| dc.contributor.author | Altuner, Durdu | |
| dc.contributor.author | Gunay, Murat | |
| dc.contributor.author | Suleyman, Halis | |
| dc.date.accessioned | 2026-10-18T20:26:37.016966191Z | |
| dc.date.available | 2026-10-18T20:26:37.016966191Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Aim: The current study aimed to investigate the protective effects of adenosine triphosphate (ATP), metyrosine, and melatonin on possible methylphenidate cardiotoxicity in rats using biochemical and histopathological methods. Methods: Thirty rats were separated into five groups: healthy (HG), methylphenidate (MP), ATP + methylphenidate (ATMP), metyrosine + methylphenidate (MSMP), and melatonin + methylphenidate (MLMP). ATP (5 mg/kg) was given intraperitoneally once daily, metyrosine (50 mg/kg) orally twice daily, and melatonin (10 mg/kg) orally once daily. Methylphenidate (10 mg/kg) was administered orally once daily for 1 h after ATP, metyrosine and melatonin. The protocol was repeated for 30 days. Subsequently, blood samples were taken from the tail veins of the animals to measure adrenaline, noradrenaline, dopamine, troponin I (TP I) and creatine kinase MB (CK-MB) levels; the animals were then euthanized and the heart tissues were extracted. Tissues were analyzed for malondialdehyde (MDA), total glutathione (tGSH), superoxide dismutase (SOD), and catalase (CAT) and histopathologically. Results: In MP group, MDA, adrenaline, noradrenaline, dopamine, TP I, and CK-MB levels increased (p < 0.001) and tGSH, SOD, and CAT levels decreased (p < 0.001) compared to HG, and histopathologic damage developed. Oxidant levels were lower and antioxidant levels were higher in ATMP, MSMP, and MLMP groups compared to MP group (p < 0.001). Catecholamine levels were measured lower in the MSMP group compared to the MP group (p < 0.001). TP I and CK-MB levels were lower in ATMP, MSMP and MLMP groups compared to MP (p < 0.05), with the lowest being in rats given ATP (p < 0.001). ATP, melatonin, and metirozin applications were effective to different degrees in preventing histopathological changes. Conclusion: This study may guide clinical trials using ATP and melatonin to prevent methylphenidate-induced myocardial injury. Copyright © 2025 Emir, Bulut, Suleyman, Mammadov, Yucel, Cicek, Yazici, Altuner, Gunay and Suleyman. | |
| dc.identifier.doi | 10.3389/fphar.2024.1503032 | |
| dc.identifier.eissn | 1663-9812 | |
| dc.identifier.issn | 1663-9812 | |
| dc.identifier.pmcid | PMC11739286 | |
| dc.identifier.pmid | 39830352 | |
| dc.identifier.scopus | 2-s2.0-85214991150 | |
| dc.identifier.startpage | 1503032 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/11586 | |
| dc.identifier.volume | 15 | |
| dc.identifier.wos | WOS:001398456400001 | |
| dc.language.iso | en | |
| dc.publisher | Frontiers Media SA | |
| dc.relation.ispartof | Frontiers in Pharmacology | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | adenosine triphosphate | |
| dc.subject | melatonin | |
| dc.subject | methylphenidate | |
| dc.subject | metyrosine | |
| dc.subject | oxidative stress | |
| dc.subject | catalase | |
| dc.subject | catecholamine | |
| dc.subject | creatine kinase MB | |
| dc.subject | dopamine | |
| dc.subject | epinephrine | |
| dc.subject | glutathione | |
| dc.subject | malonaldehyde | |
| dc.subject | metirosine | |
| dc.subject | noradrenalin | |
| dc.subject | superoxide dismutase | |
| dc.subject | troponin I | |
| dc.subject | animal experiment | |
| dc.subject | animal tissue | |
| dc.subject | Article | |
| dc.subject | biochemical analysis | |
| dc.subject | blood sampling | |
| dc.subject | cardiotoxicity | |
| dc.subject | chemical analysis | |
| dc.subject | controlled study | |
| dc.subject | enzyme activity | |
| dc.subject | enzyme linked immunosorbent assay | |
| dc.subject | heart injury | |
| dc.subject | high performance liquid chromatography | |
| dc.subject | histopathology | |
| dc.subject | nonhuman | |
| dc.title | Pathogenesis-directed therapy of methylphenidate-induced oxidative heart damage in rats | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 3 | |
| rdl.citation.wos | 3 | |
| rdl.department | Department of Cardiovascular Surgery, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Türkiye. | Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Türkiye. | Pharmacy Services Program, Vocational School of Health Services, Erzincan Binali Yildirim University, Erzincan, Türkiye. | Department of Physiology, Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Türkiye. | Department of Histology and Embryology, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan, Türkiye. | Biochemistry Laboratory, Erzincan Mengücek Gazi Training and Research Hospital, Erzincan Binali Yildirim University, Erzincan, Türkiye. | |
| rdl.oa.status | gold | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
